Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype

Clinical Pharmacology and Therapeutics
L BertilssonT Villén

Abstract

Single oral 10 mg doses of diazepam and demethyldiazepam were given on different occasions to 16 healthy subjects. The subjects included four poor hydroxylators of debrisoquin and three poor hydroxylators of mephenytoin. There was a correlation between the total plasma clearance of diazepam and demethyldiazepam (rs = 0.83; p less than 0.01). There was no relationship between benzodiazepine disposition and debrisoquin hydroxylation. Poor hydroxylators of mephenytoin had less than half the plasma clearance of both diazepam (p = 0.0008) and demethyldiazepam (p = 0.0001) compared with extensive hydroxylators of mephenytoin. The plasma half-lives were longer in poor hydroxylators than they were in extensive hydroxylators of mephenytoin for both diazepam (88.3 +/- SD 17.2 and 40.8 +/- 14.0 hours; p = 0.0002) and demethyldiazepam (127.8 +/- 23.0 and 59.0 +/- 16.8 hours; p = 0.0001). There was no significant difference in volume of distribution of the benzodiazepines between the phenotypes. This study shows that the metabolism of both diazepam (mainly demethylation) and demethyldiazepam (mainly hydroxylation) is related to the mephenytoin, but not to the debrisoquin, hydroxylation phenotype.

Citations

Jun 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Feb 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Dec 1, 1991·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Y HorsmansD Pessayre
Jan 1, 1991·Fundamental & Clinical Pharmacology·G Alván
Jun 1, 1995·Clinical Pharmacology and Therapeutics·J D BalianD A Flockhart
Feb 1, 1994·Acta Anaesthesiologica Scandinavica·O Spigset
May 20, 1998·Clinical Pharmacology and Therapeutics·J K LambaK K Kohli
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A Bernard, E Bruera
Apr 3, 2002·Pharmacogenetics·Wichittra TassaneeyakulDhanu Gaysornsiri
Oct 16, 2002·Journal of Sex & Marital Therapy·Alexandra Zourková, Eva Hadasová
Jan 13, 2004·Neurotoxicity Research·V Ravindranath
Sep 3, 2004·Journal of Clinical Pharmacology·Kiman KimHartmut Derendorf
Nov 8, 2007·The Annals of Pharmacotherapy·Milo Gibaldi
Feb 26, 2008·British Journal of Clinical Pharmacology·R Michael BaldwinLeif Bertilsson
May 13, 2009·Journal of Neural Transmission·Arun K TiwariDaniel J Müller
Jun 19, 2012·Current Psychiatry Reports·Brett A EnglishStanford Jhee
May 29, 2015·Journal of Clinical Psychopharmacology·Anna K GarménJonatan D Lindh
Apr 22, 2016·European Journal of Clinical Pharmacology·Manu JoseAdithan Chandrasekaran
May 1, 1989·British Journal of Clinical Pharmacology·A DrøhseL F Gram
Aug 1, 1990·Pharmacology & Toxicology·S Loft, H E Poulsen
May 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T V BeischlagT Inaba
Aug 1, 1996·Clinical Pharmacology and Therapeutics·J S MarinacD A Flockhart
Dec 1, 1995·Journal of Clinical Psychopharmacology·T A KetterA M Callahan
Jul 1, 1995·Clinical Pharmacology and Therapeutics·Y CaracoA J Wood
Nov 1, 1996·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S OnoT Satoh
Jul 1, 1993·Pharmacology & Toxicology·A LlerenaL Bertilsson
May 1, 1997·Clinical Pharmacology and Therapeutics·D R SohnT Ishizaki
Sep 24, 2004·Therapeutic Drug Monitoring·Takashi FukasawaKoichi Otani
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jiro KajitaHiroyuki Kobayashi
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·H G XieC M Stein
Sep 3, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Aleksandra GaletinJ Brian Houston
Jul 17, 2008·Epilepsia·Wolfgang LöscherDieter Schmidt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.